We are thrilled to announce that @US_FDA has approved the world's first disease-modifying drug for #Type1Diabetes 🎉
🌟 #Teplizumab is a game-changing drug that can delay #type1 for up to 3 years in people most at risk! 🌟
Read more: https://t.co/ZlH7KdMhUg #GBDoc#T1D @JDRF
More good news coming from the teplizumab prevention trial. A single course of treatment delays a #T1D diagnosis by almost 36 months.
3 years of no insulin injections, no finger pricks, no site changes. If you don’t think it’s meaningful, ask anyone with T1D to explain it.
RESEARCH. A JDRF-supported clinical trial showed immunotherapy Teplizumab delayed the onset of #type1diabetes by an average of two years in people identified by @T1D_TrialNet's Pathway to Prevention study at high risk of the condition. Read more: https://t.co/BjceH74OXG #GBDoc
Is T1D a heterogeneous disease? A paper by two @JDRF-funded researchers concludes that yes it is--with two different, age of diagnosis-dependent endotypes.
https://t.co/U7CndzIph4
Great to hear that the biscuits are going down well! At times like these it's more important than ever for us to make sure our staff are well looked after and taking regular breaks.
Today we opened our pop-up emergency supplies food support service at St Thomas' Hospital marquee for staff who are struggling to get to the supermarket at the moment.
All items have been kindly donated or purchased by @GSTTCharity and are available to staff for free.
#TeamGSTT
The health and safety of our TrialNet participants and their families are always our top priority. To learn about temporary changes to TrialNet studies and operations as a result of current coronavirus precautions, please visit our website at https://t.co/kBI9Uz7HhT
JDRF Coronavirus / Covid19 Information: Information about the Coronavirus/Covid19 outbreak, aimed for people and families living with type 1 diabetes. https://t.co/bD6vjzf6Fs
Following the latest government announcement yesterday, we’ve updated our #coronavirus advice for people living with #diabetes. Find the latest advice, including FAQs, here, and we’ll continue to update as soon as possible when we learn more: https://t.co/wgOlvkMgvW
We understand that you may be concerned about the ongoing coronavirus (COVID-19) situation.
Our website includes the actions we are taking to care for patients and reduce the risk of spreading the infection: https://t.co/U0ChzhY0al
@castletoncollin There is a lot of missing co-morbidity data here, over 50% of total cases and about 60% of deaths. Difficult to draw clear conclusions
Student shares her diabetes-CBT thought diary with me in clinic. If you do not have #diabetes, now try to imagine living with these painful recurrent negative diabetes thoughts-day in day out? That's what empathy is. Patient has given written permission to share